(CR-031) A retrospective comparison of two matrices for diabetic foot ulcer closure

Diabetic foot ulcers (DFUs) are usually refractive to traditional care and require advanced materials, such as matrices, to promote healing. These matrices come from different sources and exhibit different properties, so it is still unclear whether there are advantages in using one type over others. Here, we conducted a chart review of patients with DFUs who received a polylactic acid (PLA) synthetic matrix vs. those who received a fish skin xenograft and compare the rate of wound closure by 12 weeks and the time needed to attain full closure of the wound.

Methods:

This was a retrospective study of patients with DFUs of at least 12 weeks of age and >1 cm2 without infection who received either PLA or fish skin matrices as adjuncts to their standard of care. All patients were followed weekly for 12 weeks with applications of the matrices on every visit. The size of the wounds and the time until complete healing were recorded, as well as the rate of wound closure by the end of the follow-up period.

Results:

Twenty-two patients received PLA matrices and 24 fish skin xenografts. Baseline data, including clinical characteristics, wound size, and location, was similar between groups. For the healed wounds, the mean time to attain full closure was 10.3 ± 5.1 vs. 12.7 ± 5.1 weeks in the PLA vs. Xenograft groups (p = 0.048). Moreover, only 4 patients (18%) in the PLA group did not achieve complete healing by 12 weeks, compared to 13 (54%) in the xenograft group (p = 0.011).

Discussion:

The ideal matrix for DFU treatment should be a material that promotes rapid healing, is easily integrated into native tissue, does not elicit an aggressive immune or anaphylactic response, and is easily degraded. Synthetic materials such as PLA fulfill these criteria and are well-positioned for reimbursability in their use. Here, we show that compared to fish xenografts, a responsibly sourced novel material that is gaining acceptance as a skin substitute, PLA matrices achieve a faster time-to-heal response while increasing by 64% the odds of attaining full closure by 12 weeks.

Trademarked Items: SupraSDRM

References: 1. Edmonds M, Manu C, Vas P. The current burden of diabetic foot disease. Journal of Clinical Orthopaedics and Trauma. 2021 Jun 1;17:88–93.
2. Mirhaj M, Labbaf S, Tavakoli M, Seifalian AM. Emerging treatment strategies in wound care. Int Wound J. 2022 Nov;19(7):1934–54.
3. Hundeshagen G, Collins VN, Wurzer P, Sherman W, Voigt CD, Cambiaso-Daniel J, et al. A Prospective, Randomized, Controlled Trial Comparing the Outpatient Treatment of Pediatric and Adult Partial-Thickness Burns with Suprathel or Mepilex Ag. J Burn Care Res. 2018 Feb 20;39(2):261–7.
4. Stone R, Saathoff EC, Larson DA, Wall JT, Wienandt NA, Magnusson S, et al. Accelerated Wound Closure of Deep Partial Thickness Burns with Acellular Fish Skin Graft. Int J Mol Sci. 2021 Feb 4;22(4):1590.
5. Ring A, Goertz O, Al-Benna S, Ottomann C, Langer S, Steinstraesser L, et al. Accelerated angiogenic induction and vascular integration in a novel synthetic scaffolding matrix for tissue replacement. Int J Artif Organs. 2010 Dec;33(12):877–84.